Deng Y, Zheng H, Li B, Huang F, Qiu Y, Yang Y, et al
Commercial Payers: Commercial payers generally follow CPT and CMS guidance but often layer on additional requirements
In Europe, the European Medicines Agency supports two main regulatory tracks: well-established use and traditional use registration under Directive 2004/24/EC, which requires data on safety, efficacy, and pharmacovigilance
Li P, Lv H, Yang H, Qian JM
Although some studies have confirmed that neutrophils are significantly active in the peripheral blood of SA patients (30) and that the autophagy and extracellular DNA traps of peripheral blood neutrophils could enhance asthma severity by damaging the airway epithelium and triggering inflammatory responses of airway epithelial cells and peripheral blood eosinophils (31), the role of neutrophils in the peripheral blood in the diagnosis of asthma and the judgment of its severity have not yet been determined